Shin et al. reported that CD4+ T cell-derived exosomes enhanced the antitumor response of CD8+ T cells through miR-25-3p, miR-155-5p, miR-215-5p, and miR-375 without affecting regulatory T cells, resulting in the suppression of melanoma growth. Here, CD8A is linked to melanoma.